Specialty Pharmacy

Top news of the week in oncology and cancer drug development.

A robust data reporting infrastructure would greatly benefit specialty pharmacy stakeholders.

Laquinimod fails to outperform placebo in patients with relapsing-remitting MS.

Top news of the day from across the health care landscape.

Gregory R. Morris, chief commercial officer at VirMedica, discusses the eAccess program for specialty pharmacies.

Top articles of the week on Specialty Pharmacy Times.

Keytruda improved overall response rate and progression free survival in NSCLC.

HIV has become a chronic disease that requires a different strategy with aging patients.

Findings highlight the need for continuous safety monitoring of novel therapeutics.

Health care use before an initial demyelinating event suggests a measureable prodromal period in multiple sclerosis.

Top news of the day from across the health care landscape.

Suzette DiMascio, CHE, CMCE, CPC, president and CEO of CSI Specialty Group, discusses how specialty pharmacies help advance the goals of accountable care organizations.

Patients diagnosed with colorectal cancer are at a higher risk for mood disorders such as depression, bipolar disorder, and anxiety.

Altered stem cells are capable of developing into cartilage cells that create a biologic anti-inflammatory drug.

The use of specialty drugs for weight loss, building muscle mass, or for cosmetic purposes carries risky implications.

New data provides insight into the safety and efficacy of the FDA-approved multiple sclerosis drug.

The study is the first to demonstrate that CRISPR/Cas9 technology may lead to an HIV cure.

Top news of the day from across the health care landscape.

Scott Gottlieb has served as the FDA Deputy Commissioner under President George W. Bush, a senior advisor to the FDA commissioner, and as FDA Director of Medical Policy Development.

Avelumab (Bavenico) approved for advanced or metastatic urothelial carcinoma.

Substantial proportion of patients with ulcerative colitis or Crohn’s disease achieved mucosal healing with vedolizumab.

MedChew Rx is a cannabidiol that treats pain and spasticity associated with multiple sclerosis.

Kisqali Femara Co-Pack only requires 1 co-payment.

Top news of the day from across the health care landscape.

A malaria protein combined with an anti-cancer drug shows promise against chemotherapy-resistant bladder cancer.

Data show communication failure accounted for 71% of serious or life-threatening errors related to medication errors.

The current outlook for biosimilar manufacturers shows significant promise.